Belimumab Shows Benefits for Lupus Nephritis

(MedPage Today) -- Patients with lupus nephritis who received belimumab (Benlysta) plus standard therapy were significantly more likely to have a renal response at 2 years than those given placebo plus standard care, a large randomized trial found...